BDBM223746 US9540377, 12.8::n-[(1r)-1- cyclobutylethyl]-7- [(trans-4- methylcyclohexyl)methyl]- 8-[4-(propan-2- yl)pyridin-2-yl]-2-(1h- tetrazol-5-yl)-7h-purin-6- amine

SMILES CC(C)c1ccnc(-c2nc3nc(-c4nnn[nH]4)nc(N[C@H](C)C4CCC4)c3n2C[C@H]2CC[C@H](C)CC2)c1

InChI Key InChIKey=NBXONUCFOYIQCU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 223746   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 223746BDBM223746(US9540377, 12.8 | n-[(1r)-1- cyclobutylethyl]-7- [...)
Affinity DataIC50: 1.91nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent